Your search returned 2 results.

Results
	1.	Cefiderocol versus high-dose, extended-infusion meropenem for the treatment of Gram-negative nosocomial pneumonia (APEKS-NP): a randomised, double-blind, phase 3, non-inferiority trial. MedStar authors: Shorr, Andrew F PMID: 33058798 Year: 2021 Citation: The Lancet Infectious Diseases. 21(2):213-225, 2021 02. Institution: MedStar Washington Hospital Center Department: Medicine/Pulmonary-Critical Care Medline publication type: Journal Article Form of publication: Journal Article All authors: Ariyasu M, Clevenbergh P, Echols R, Kaye KS, Kollef M, Matsunaga Y, Menon A, Nagata TD, Pogue JM, Shorr AF, Timsit JF, Wunderink RG, Zeitlinger M DOI: https://dx.doi.org/10.1016/S1473-3099(20)30731-3 Add to cart (remove)
	2.	Assessment of ceftaroline fosamil in the treatment of community-acquired bacterial pneumonia due to Streptococcus pneumoniae: insights from two randomized trials. MedStar authors: Shorr, Andrew F PMID: 23357290 Year: 2013 Citation: Diagnostic Microbiology & Infectious Disease. 75(3):298-303, 2013 Mar. Institution: MedStar Washington Hospital Center Department: Medicine/Pulmonary-Critical Care Medline publication type: Clinical Trial, Phase III Journal Article Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Eckburg PB, Friedland HD, Kollef M, Llorens L, Shorr AF DOI: http://dx.doi.org/10.1016/j.diagmicrobio.2012.12.002 Add to cart (remove)

Refine your search